Clinical Trial Update: A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and tolerability of titration and continuous subcutaneous infusion of ABBV-951 in outpatients with Parkinson's disease. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABBV-951

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: COMPLETED